Clinical Trial Update: Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial [Phase 3]

View source ↗

Summary

A Phase 3 pivotal trial evaluating nicotinamide for chemoprevention of keratinocyte carcinoma in solid organ transplant recipients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma
• Keratinocyte Carcinoma
• Non-melanoma Skin Cancer

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Women's College Hospital | Conditions: Non-melanoma Skin Cancer, Carcinoma, Squamous Cell | Phase 3 | Status: RECRUITING